{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2018-N-0236\" sorted by posted_date descending", "rows": [["FDA-2018-N-0236-0055", "FDA", "FDA-2018-N-0236", "Reference 20 - Final Regulatory Flexibility Analysis 5 Oct 2021", "Supporting & Related Material", "Background Material", "2021-10-19T04:00:00Z", 2021, 10, null, null, "2021-10-19T14:16:28Z", null, 0, 0, "0900006484dcb011"], ["FDA-2018-N-0236-0037", "FDA", "FDA-2018-N-0236", "Ref 6 - CDRH Patient Engagement web page RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:57:53Z", null, 0, 0, "0900006484dbb09a"], ["FDA-2018-N-0236-0036", "FDA", "FDA-2018-N-0236", "Ref 5 - De Novo Classification Process (Evaluation of Automatic Class III Designation) RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:55:01Z", null, 0, 0, "0900006484dbb09b"], ["FDA-2018-N-0236-0038", "FDA", "FDA-2018-N-0236", "Ref 7 - Procedures for Meetings of the Medical Devices Advisory Committee RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:59:35Z", null, 0, 0, "0900006484dbb0d6"], ["FDA-2018-N-0236-0049", "FDA", "FDA-2018-N-0236", "RIA Ref 1 Proposed Rule RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:13:38Z", null, 0, 0, "0900006484dbb0e2"], ["FDA-2018-N-0236-0054", "FDA", "FDA-2018-N-0236", "RIA Ref 6 Medical_Devices_Top_Markets_Report RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:18:23Z", null, 0, 0, "0900006484dbb0e4"], ["FDA-2018-N-0236-0053", "FDA", "FDA-2018-N-0236", "RIA Ref 5 NAICS 339100 May 2019 BLS OES RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:17:23Z", null, 0, 0, "0900006484dbb0e6"], ["FDA-2018-N-0236-0039", "FDA", "FDA-2018-N-0236", "Ref 8 - eCopy Program for Medical Device Submissions RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:00:28Z", null, 0, 0, "0900006484dbb0d8"], ["FDA-2018-N-0236-0050", "FDA", "FDA-2018-N-0236", "RIA Ref 2 Preliminary RIA RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:14:57Z", null, 0, 0, "0900006484dbb0e1"], ["FDA-2018-N-0236-0028", "FDA", "FDA-2018-N-0236", "Medical Device De Novo Classification Process", "Rule", "Final Rule", "2021-10-05T04:00:00Z", 2021, 10, "2021-10-05T04:00:00Z", null, "2021-10-05T16:21:46Z", "2021-21677", 0, 0, "0900006484dbaa56"], ["FDA-2018-N-0236-0030", "FDA", "FDA-2018-N-0236", "Ref 2 - Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:46:08Z", null, 0, 0, "0900006484dbb099"], ["FDA-2018-N-0236-0031", "FDA", "FDA-2018-N-0236", "Ref 1 - Content of Premarket Submissions for Management of Cybersecurity in Medical Devices RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:46:54Z", null, 0, 0, "0900006484dbb09c"], ["FDA-2018-N-0236-0052", "FDA", "FDA-2018-N-0236", "RIA Ref 4 HHS_RIAGuidance RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:16:33Z", null, 0, 0, "0900006484dbb0e5"], ["FDA-2018-N-0236-0029", "FDA", "FDA-2018-N-0236", "Medical Device De Novo Classification Process Final Rule References List re: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:44:02Z", null, 0, 0, "0900006484dbb098"], ["FDA-2018-N-0236-0032", "FDA", "FDA-2018-N-0236", "Ref 3 - Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:55:35Z", null, 0, 0, "0900006484dbb09d"], ["FDA-2018-N-0236-0035", "FDA", "FDA-2018-N-0236", "Ref 4-Patient Preference Information--Voluntary Submission Review in Premarket Approval Applications Humanitarian Device Exemption Applications and De Novo Req RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:56:47Z", null, 0, 0, "0900006484dbb09e"], ["FDA-2018-N-0236-0040", "FDA", "FDA-2018-N-0236", "Ref 11 - Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:02:01Z", null, 0, 0, "0900006484dbb0d5"], ["FDA-2018-N-0236-0046", "FDA", "FDA-2018-N-0236", "Ref 17 - User Fees for 513(g) Requests for Information RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:09:37Z", null, 0, 0, "0900006484dbb0d7"], ["FDA-2018-N-0236-0042", "FDA", "FDA-2018-N-0236", "Ref 13 - Requests for Feedback and Meetings for Medical Device Submissions - The Q-Submission Program RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:04:49Z", null, 0, 0, "0900006484dbb0db"], ["FDA-2018-N-0236-0048", "FDA", "FDA-2018-N-0236", "Ref 19 - Emergency Use Authorization of Medical Products and Related Authorities RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:11:44Z", null, 0, 0, "0900006484dbb0e0"], ["FDA-2018-N-0236-0034", "FDA", "FDA-2018-N-0236", "Ref 10 - The 510(k) Program-  Evaluating Substantial Equivalence in Premarket Notifications (510(k)) RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:56:38Z", null, 0, 0, "0900006484dbb0da"], ["FDA-2018-N-0236-0041", "FDA", "FDA-2018-N-0236", "Ref 12 - The Least Burdensome Provisions- Concept and Principles RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:04:01Z", null, 0, 0, "0900006484dbb0d9"], ["FDA-2018-N-0236-0045", "FDA", "FDA-2018-N-0236", "Ref 16 - Acceptance Review for De Novo Classification Requests RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:08:40Z", null, 0, 0, "0900006484dbb0dd"], ["FDA-2018-N-0236-0044", "FDA", "FDA-2018-N-0236", "Ref 15 - Recommended Content and Format of Non-Clinical Bench Performance Testing Information in Premarket Submissions RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:07:31Z", null, 0, 0, "0900006484dbb0df"], ["FDA-2018-N-0236-0051", "FDA", "FDA-2018-N-0236", "RIA Ref 3 Ross Ginsburg 2003 RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:15:48Z", null, 0, 0, "0900006484dbb0e3"], ["FDA-2018-N-0236-0033", "FDA", "FDA-2018-N-0236", "Ref 9 - Consideration of Uncertainty in Making Benefit-Risk Determinations in Medical Device Premarket Approvals De Novo Classifications and Humanitarian Device RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T19:56:30Z", null, 0, 0, "0900006484dbb09f"], ["FDA-2018-N-0236-0047", "FDA", "FDA-2018-N-0236", "Ref 18 - FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food Drug and Cosmetic Act RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:10:46Z", null, 0, 0, "0900006484dbb0dc"], ["FDA-2018-N-0236-0043", "FDA", "FDA-2018-N-0236", "Ref 14 - Use of Electronic Health Record Data in Clinical Investigations RE: Medical Device De Novo Classification Process", "Supporting & Related Material", "Background Material", "2021-10-05T04:00:00Z", 2021, 10, null, null, "2021-10-05T20:05:59Z", null, 0, 0, "0900006484dbb0de"], ["FDA-2018-N-0236-0010", "FDA", "FDA-2018-N-0236", "06 - Reference 5 - FDA's guidance Collection of Race and Ethnicity Data in Clinical Trials", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:28:59Z", null, 0, 0, "090000648390d0be"], ["FDA-2018-N-0236-0014", "FDA", "FDA-2018-N-0236", "10 - Reference 9 - Patient Preference Information--Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests . . .", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:32:11Z", null, 0, 0, "090000648390d0c2"], ["FDA-2018-N-0236-0009", "FDA", "FDA-2018-N-0236", "05 - Reference 4 - FDA's Guidance Collection of Race and Ethnicity Data in Clinical Trials", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:28:19Z", null, 0, 0, "090000648390d0bd"], ["FDA-2018-N-0236-0013", "FDA", "FDA-2018-N-0236", "09 - Reference 8 - FDA's Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-26T20:09:39Z", null, 0, 0, "090000648390d0c1"], ["FDA-2018-N-0236-0005", "FDA", "FDA-2018-N-0236", "01 - List of References", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:25:30Z", null, 0, 0, "090000648390cc75"], ["FDA-2018-N-0236-0015", "FDA", "FDA-2018-N-0236", "11 - Reference 10 - Preliminary Analysis of Economic Impacts", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-26T19:59:25Z", null, 0, 0, "090000648390d0c3"], ["FDA-2018-N-0236-0006", "FDA", "FDA-2018-N-0236", "02 - Reference 1 - De Novo Classification Process (Evaluation of Automatic Class III Designation) - Final Guidance", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-26T19:59:00Z", null, 0, 0, "090000648390cc76"], ["FDA-2018-N-0236-0012", "FDA", "FDA-2018-N-0236", "08 - Reference 7 - Use of International Standard ISO-10993, Biological evaluation of medical devices--Part 1-  Evaluation and testing within a risk management process", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:30:25Z", null, 0, 0, "090000648390d0c0"], ["FDA-2018-N-0236-0011", "FDA", "FDA-2018-N-0236", "07 - Reference 6 - FDA's guidance Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:29:43Z", null, 0, 0, "090000648390d0bf"], ["FDA-2018-N-0236-0008", "FDA", "FDA-2018-N-0236", "04 - Reference 3 - FDA's guidance - eCopy Program for Medical Device Submissions", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-15T19:27:37Z", null, 0, 0, "090000648390cc78"], ["FDA-2018-N-0236-0007", "FDA", "FDA-2018-N-0236", "03 - Reference 2 - FDA's guidance \"Procedures for Class II Device Exemptions from Premarket Notification\"", "Supporting & Related Material", "Background Material", "2019-02-15T05:00:00Z", 2019, 2, null, null, "2019-02-26T19:31:29Z", null, 0, 0, "090000648390cc77"], ["FDA-2018-N-0236-0001", "FDA", "FDA-2018-N-0236", "Medical Device De Novo Classification Process", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2018-12-07T05:00:00Z", 2018, 12, "2018-12-07T05:00:00Z", "2019-03-08T04:59:59Z", "2019-03-09T02:01:03Z", "2018-26378", 0, 0, "090000648395870c"]], "truncated": false, "filtered_table_rows_count": 40, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2018-N-0236"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-0236", "results": [{"value": "FDA", "label": "FDA", "count": 40, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-0236", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 38, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2018-N-0236", "results": [{"value": 2021, "label": 2021, "count": 28, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&posted_year=2021", "selected": false}, {"value": 2019, "label": 2019, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&posted_year=2019", "selected": false}, {"value": 2018, "label": 2018, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&posted_year=2018", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2018-N-0236&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 44.37279101694003, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}